Reversible Cerebral Vasoconstriction Syndrome: Systematic Appraisal of the Literature
##plugins.themes.bootstrap3.article.details##
Introduction: The reversible cerebral vasoconstriction syndrome encompasses a wide range of etiologies that present clinically with thunderclap headache, can recur over a period of 1-3 weeks and can be associated with neurological symptoms such as seizures, ischemia, stroke and non aneurysmatic subarachnoid hemorrhage.
Materials and Methods: Literature search was performed and subsequently the clinical and pathological features of this syndrome were reviewed, plus we discuss: Pathophysiology, diagnosis, treatment, and potential complications.
Conclusions: The reversible cerebral vasoconstriction syndrome is a diagnostic challenge because of its low incidence and multiple forms of presentation is very important to develop detailed medical record, for an early diagnosis.
síndrome, vasoconstricción, reversible, cerebral, Syndrome, vasoconstriction, reversible, cerebral,
2. Garcin B, Clouston J, Saines N. Reversible cerebral vasoconstriction syndrome. J Clin Neurosci. 2009;16:147-150. doi:10.1016/j.jocn.2008.03.014.
3. Dodick DW, Brown Jr RD, Britton JW, Huston 3rd J. Nonaneurysmal thunderclap headache with diffuse, multifocal, segmental, and reversible vasospasm. Cephalalgia. 1999;19:118-23.
4. Calabrese LH, Dodick DW, Schwedt TJ, Singhal AB. Narrative review: reversible cerebral vasoconstriction syndromes. Ann Intern Med. 2007;146:34-44.
5. Ducros A, Boukobza M, Porcher R, et al. The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome: A prospective series of 67 patients. Brain. 2007;130:3091-101.
6. Slivka A, Philbrook B. Clinical and angiographic features of thunderclap headache. Headache 1995;35:1–6
7. Ducros A, Bousser MG. Reversible cerebral vasoconstriction syndrome. Pract Neurol. 2009;9:256-67.
8. Chen SP, Fuh JL, Chang FC, et al. Transcranial color Doppler study for reversible cerebral vasoconstriction syndromes. Ann Neurol. 2008;63:751-7.
9. Chen S-P, Fuh J-L, Wang S-J. Reversible cerebral vasoconstriction syndrome: current and future perspectives. Expert review of neurotherapeutics [Internet]. 2011 Sep;11(9):1265-76. Disponible en:http://www.ncbi.nlm.nih.gov/pubmed/21864073
10. Williams TL, Lukovits TG, Harris BT, Harker Rhodes C. A fatal case of postpartum cerebral angiopathy with literature review. Arch Gynecol Obstet. 2007 Jan;275(1):67-77.
11. Zuber M, Touze E, Domigo V, Trystram D, Lamy C, Mas JL. Reversible cerebral angiopathy: efficacy of nimodipine. J Neurol. 2006 Dec;253(12):1585-8.
12. Ducros A. Reversible cerebral vasoconstriction syndrome. Lancet Neurol [internet]. 2012;11:906-17. Disponible en: http://linkinghub.elsevier.com/retrieve/pii/S1474-4422(12)70135-7.
13. Bartynski WS. Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol. 2008;29:1043-9.
14. Singhal AB. Postpartum angiopathy with reversible posterior leukoencephalopathy. Arch Neurol. 2004;61:411-6.
15. Chen SP, Fuh JL, Lirng JF, Chang FC, Wang SJ. Recurrent primary thunderclap headache and benign CNS angiopathy: spectra of the same disorder? Neurology. 2006;67:2164-9.
16. Hajj-Ali RA, Furlan A, Abou-Chebel A, Calabrese LH. Benign angiopathy of the central nervous system: cohort of 16 patients with clinical course and long-term followup. Arthritis Rheum. 2002;47:662-9.
17. Lu SR, Liao YC, Fuh JL, Lirng JF, Wang SJ. Nimodipine for treatment of primary thunderclap headache. Neurology. 2004;62:1414-6.